{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:19Z","timestamp":1793141839189,"version":"4.5.0"},"reference-count":152,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Uveal melanoma represents the most prevalent form of primary malignant intraocular tumor in adults. Historically, enucleation was considered the gold-standard approach in the treatment of uveal melanoma. Currently, radiotherapy is the most commonly used therapy, aiming at a better quality of life. However, radiotherapy can result in several ocular complications, some of which may be vision-threatening. Radiation-induced dry eye, scleral necrosis, cataract, rubeosis iridis, neovascular glaucoma, radiation retinopathy, maculopathy, and optic neuropathy are the most common complications. This article aims to summarize the current literature regarding the ocular complications after radiotherapy, as well as their clinical features, risk factors, and management strategies. A thorough understanding of these issues is crucial for ophthalmologists and oncologists to provide optimal patient care, improve visual outcomes, and minimize long-term complications.<\/jats:p>","DOI":"10.3390\/curroncol30070470","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T01:47:14Z","timestamp":1688435234000},"page":"6374-6396","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Radiotherapy in Uveal Melanoma: A Review of Ocular Complications"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8070-5948","authenticated-orcid":false,"given":"Lamprini","family":"Banou","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-8683","authenticated-orcid":false,"given":"Zoi","family":"Tsani","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Arvanitogiannis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pavlaki","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dastiridou","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5303-7793","authenticated-orcid":false,"given":"Sofia","family":"Androudi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13244-021-01001-w","article-title":"Diagnostic Methods and Therapeutic Options of Uveal Melanoma with Emphasis on MR Imaging\u2014Part II: Treatment Indications and Complications","volume":"12","author":"Foti","year":"2021","journal-title":"Insights Imaging"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal Melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ajo.2004.07.006","article-title":"The Collaborative Ocular Melanoma Study (COMS) Randomized Trial of Pre-Enucleation Radiation of Large Choroidal Melanoma: IV. Ten-Year Mortality Findings and Prognostic Factors. COMS Report Number 24","volume":"138","author":"Hawkins","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_4","unstructured":"Kamrava, M., Lamb, J., Sober\u00f3n, V., and McCannel, T.A. (2019). Clinical Ophthalmic Oncology, Springer International Publishing."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Piperno-Neumann, S., Piulats, J.M., Goebeler, M., Galloway, I., Lugowska, I., Becker, J.C., Vihinen, P., Van Calster, J., Hadjistilianou, T., and Proen\u00e7a, R. (2019). Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer. Cancers, 11.","DOI":"10.3390\/cancers11060817"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4103\/ijo.IJO_1478_21","article-title":"Patients Presenting with Stage IV Uveal Melanoma: Lessons Learned","volume":"70","author":"Garg","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0301-4738.154367","article-title":"Uveal Melanoma: Estimating Prognosis","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.31557\/APJCP.2022.23.5.1791","article-title":"Global Incidence and Trend of Uveal Melanoma from 1943\u20132015: A Meta-Analysis","volume":"23","author":"Naseripour","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal Melanoma: Relatively Rare but Deadly Cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1758834018757175","DOI":"10.1177\/1758834018757175","article-title":"Treatment of Uveal Melanoma: Where Are We Now?","volume":"10","author":"Yang","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rodrigues, M., de Koning, L., Coupland, S.E., Jochemsen, A.G., Marais, R., Stern, M.H., Valente, A., Barnhill, R., Cassoux, N., and Evans, A. (2019). So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020. Cancers, 11.","DOI":"10.3390\/cancers11071032"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"ref_13","unstructured":"Edge, S.B., Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F.L., and Trotti, A. (2010). AJCC Cancer Staging Manual, Springer. [7th ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal Melanoma: From Diagnosis to Treatment and the Science in Between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13244-021-01000-x","article-title":"Diagnostic Methods and Therapeutic Options of Uveal Melanoma with Emphasis on MR Imaging\u2014Part I: MR Imaging with Pathologic Correlation and Technical Considerations","volume":"12","author":"Foti","year":"2021","journal-title":"Insights Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma V. Twelve-Year Mortality Rates and Prognostic Factors: COMS Report No. 28","volume":"124","author":"Beck","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and Radiation Therapy: Current Advances and Future Directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/ICU.0000000000000761","article-title":"Radiation Therapy for Uveal Melanoma: A Review of Treatment Methods Available in 2021","volume":"32","author":"Reichstein","year":"2021","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.31348\/2020\/10","article-title":"Therapy of Uveal Melanoma. A Review","volume":"77","author":"Kasl","year":"2021","journal-title":"Czech Slovak. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Giannaccare, G., Bernabei, F., Angi, M., Pellegrini, M., Maestri, A., Romano, V., Scorcia, V., and Rothschild, P.-R. (2021). Iatrogenic Ocular Surface Diseases Occurring during and\/or after Different Treatments for Ocular Tumours. Cancers, 13.","DOI":"10.3390\/cancers13081933"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/EB.S117261","article-title":"Neurotrophic Keratitis: Current Challenges and Future Prospects","volume":"10","author":"Versura","year":"2018","journal-title":"Eye Brain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ophtha.2012.10.021","article-title":"Scleral Necrosis after Plaque Radiotherapy of Uveal Melanoma: A Case-Control Study","volume":"120","author":"Kaliki","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00417-008-0920-6","article-title":"Scleral Necrosis after Radiation Therapy for Uveal Melanomas: Report of 23 Cases","volume":"246","author":"Radin","year":"2008","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archopht.117.2.170","article-title":"Plaque Radiotherapy of Uveal Melanoma with Predominant Ciliary Body Involvement","volume":"117","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(02)01181-8","article-title":"Plaque Radiotherapy for Large Posterior Uveal Melanomas (\u22658-Mm Thick) in 354 Consecutive Patients","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.117.2.259","article-title":"Early-Onset Scleral Necrosis after Iodine I 125 Plaque Radiotherapy for Ciliochoroidal Melanoma","volume":"117","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/IAE.0b013e3181863f7c","article-title":"Corneoscleral Necrosis after Episcleral Au-198 Brachytherapy of Uveal Melanoma","volume":"29","author":"Chaudhry","year":"2009","journal-title":"Retina"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archopht.1993.01090070065021","article-title":"Severe Corneoscleral Infection","volume":"111","author":"Moriarty","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0031-1299184","article-title":"Scleritis after Proton Therapy in Uveal Melanoma","volume":"229","author":"Passarin","year":"2012","journal-title":"Klin. Monbl Augenheilkd."},{"key":"ref_30","first-page":"41","article-title":"Treatment of Uveal Melanoma by Accelerated Proton Beam","volume":"49","author":"Jager","year":"2012","journal-title":"Dev. Ophthalmol. Basel Karger"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/jcb.2019.87407","article-title":"Complications and Adverse Events of Plaque Brachytherapy for Ocular Melanoma","volume":"11","author":"Peddada","year":"2019","journal-title":"J. Contemp. Brachyther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00417-018-4032-7","article-title":"Neoadjuvant Proton Beam Irradiation vs. Adjuvant Ruthenium Brachytherapy in Transscleral Resection of Uveal Melanoma","volume":"256","author":"Pilger","year":"2018","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9394(98)00445-0","article-title":"Radiation Complications and Tumor Control after Plaque Radiotherapy of Choroidal Melanoma with Macular Involvement","volume":"127","author":"Shields","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ophtha.2020.06.030","article-title":"Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma","volume":"128","author":"Espensen","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.2147\/OPTH.S219268","article-title":"Radiation Retinopathy: Detection and Management Strategies","volume":"15","author":"Sahoo","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1097\/IAE.0000000000001874","article-title":"New Ultra\u2013Wide-Field Angiographic Grading Scheme for Radiation Retinopathy after Iodine-125 Brachytherapy for Uveal Melanoma","volume":"38","author":"McCannel","year":"2018","journal-title":"Retina"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IAE.0b013e31814b1b75","article-title":"Early Macular Morphological Changes Following Plaque Radiotherapy for Uveal Melanoma","volume":"28","author":"Horgan","year":"2008","journal-title":"Retina"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000526548","article-title":"Outcomes of Second-Line Intravitreal Anti-VEGF Switch Therapy in Radiation Retinopathy Secondary to Uveal Melanoma: Moving from Bevacizumab to Aflibercept","volume":"8","author":"Srivastava","year":"2022","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5114\/jcb.2018.77955","article-title":"Radiobiological Doses, Tumor, and Treatment Features Influence on Outcomes after Epiescleral Brachytherapy. A 20-Year Retrospective Analysis from a Single-Institution: Part II","volume":"10","author":"Miguel","year":"2018","journal-title":"J. Contemp. Brachyther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1136\/bjophthalmol-2013-303331","article-title":"Pars Plana Vitrectomy to Repair Retinal Detachment Following Brachytherapy for Uveal Melanoma","volume":"97","author":"Beykin","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/eye.2015.20","article-title":"Incidence and Indications for Pars Plana Vitrectomy Following the Treatment of Posterior Uveal Melanomas in Scotland","volume":"29","author":"Chia","year":"2015","journal-title":"Eye"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1442-9071.2009.02127.x","article-title":"Management of Exudative Retinal Detachment in Choroidal Melanoma","volume":"37","author":"Gibran","year":"2009","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/OPTH.S37938","article-title":"Intravitreal Bevacizumab Combined with Plaque Brachytherapy Reduces Melanoma Tumor Volume and Enhances Resolution of Exudative Detachment","volume":"7","author":"Murray","year":"2013","journal-title":"Clin. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/bjo.85.11.1305","article-title":"Intraocular Inflammation after Proton Beam Irradiation for Uveal Melanoma","volume":"85","author":"Lumbroso","year":"2001","journal-title":"Br. J. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ophtha.2004.09.028","article-title":"Iris and Anterior Chamber Angle Neovascularization after Iodine 125 Brachytherapy for Uveal Melanoma","volume":"112","author":"Detorakis","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajo.2014.07.002","article-title":"Prophylactic Use of Bevacizumab to Avoid Anterior Segment Neovascularization Following Proton Therapy for Uveal Melanoma","volume":"158","author":"Mantel","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/CMR.0000000000000689","article-title":"Clinical Outcomes and Secondary Glaucoma after Gamma-Knife Radiosurgery and Ruthenium-106 Brachytherapy for Uveal Melanoma: A Single Institution Experience","volume":"31","author":"Mazzini","year":"2021","journal-title":"Melanoma Res."},{"key":"ref_48","first-page":"46","article-title":"Enucleation after Stereotactic Radiosurgery in Patients with Uveal Melanoma","volume":"76","year":"2020","journal-title":"Cesk Slov. Oftalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e734","DOI":"10.1111\/aos.13418","article-title":"Incidence of Secondary Glaucoma after Treatment of Uveal Melanoma with Robotic Radiosurgery versus Brachytherapy","volume":"95","author":"Siedlecki","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bjophthalmol-2011-301420","article-title":"Baerveldt Shunts in the Treatment of Glaucoma Secondary to Anterior Uveal Melanoma and Proton Beam Radiotherapy","volume":"96","author":"Sharkawi","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/eye.2012.249","article-title":"Effects of Radiotherapy on Uveal Melanomas and Adjacent Tissues","volume":"27","author":"Groenewald","year":"2013","journal-title":"Eye"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00417-017-3834-3","article-title":"Intravitreal Bevacizumab for Neovascular Glaucoma in Uveal Melanoma Treated by Proton Beam Therapy","volume":"256","author":"Mahdjoubi","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2013.08.004","article-title":"Hypofractionated Stereotactic Photon Radiotherapy of Posteriorly Located Choroidal Melanoma with Five Fractions at Ten Gy\u2014Clinical Results after Six Years of Experience","volume":"108","author":"Dunavoelgyi","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/IAE.0b013e31827f65c8","article-title":"Does Endoresection Prevent Neovascular Glaucoma in Patient Treated with Proton Beam Irradiation?","volume":"33","author":"Cassoux","year":"2013","journal-title":"Retina"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2017.03.027","article-title":"Adjuvant Ab Interno Tumor Treatment after Proton Beam Irradiation","volume":"178","author":"Seibel","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4274\/tjo.galenos.2021.24376","article-title":"Surgical Approach in Intraocular Tumors","volume":"52","author":"Mirzayev","year":"2022","journal-title":"Turk. J. Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Romano, M.R., Catania, F., Confalonieri, F., Zollet, P., Allegrini, D., Sergenti, J., Lanza, F.B., Ferrara, M., and Angi, M. (2021). Vitreoretinal Surgery in the Prevention and Treatment of Toxic Tumour Syndrome in Uveal Melanoma: A Systematic Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810066"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjophthalmol-2013-304501","article-title":"Trans-Scleral Local Resection of Toxic Choroidal Melanoma after Proton Beam Radiotherapy","volume":"98","author":"Konstantinidis","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajo.2016.02.027","article-title":"Outcomes after Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients","volume":"165","author":"Bensoussan","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sjopt.2013.06.014","article-title":"Proton Beam Radiotherapy of Uveal Melanoma","volume":"27","author":"Damato","year":"2013","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5301\/ejo.5000236","article-title":"Tumor-Related Lipid Exudation and Associated Tumor-Related Complications after Plaque Radiotherapy of Posterior Uveal Melanoma","volume":"23","author":"Mashayekhi","year":"2013","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ophtha.2009.10.018","article-title":"Tumor-Related Lipid Exudation after Plaque Radiotherapy of Choroidal Melanoma: The Role of Bruch\u2019s Membrane Rupture","volume":"117","author":"Mashayekhi","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/2576117X.2021.1902911","article-title":"The Impacts of Episcleral Plaque Brachytherapy on Ocular Motility","volume":"71","author":"Naseripour","year":"2021","journal-title":"J. Binocul. Vis. Ocul. Motil."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaapos.2007.04.005","article-title":"Strabismus in Adults with Uveal Melanoma Following Episcleral Plaque Brachytherapy","volume":"11","author":"Dawson","year":"2007","journal-title":"J. AAPOS"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaapos.2003.09.007","article-title":"Ocular Motility Disturbances after Episcleral Plaque Brachytherapy for Uveal Melanoma","volume":"8","author":"Sener","year":"2004","journal-title":"J. AAPOS"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.ophtha.2014.05.037","article-title":"Extraocular Muscle Repositioning and Diplopia","volume":"121","author":"Nagendran","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_67","first-page":"76","article-title":"Motility Disorders in Brachytherapy of Choroid Melanomas with Ru106 Applicators","volume":"92","author":"Langmann","year":"1995","journal-title":"Ophthalmologe"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00006982-200605000-00007","article-title":"Intravitreal Triamcinolone Acetonide for Acute Radiation Papillopathy","volume":"26","author":"Shields","year":"2006","journal-title":"Retina"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/09273948.2012.689072","article-title":"Sympathetic Ophthalmia after Proton Beam Irradiation for Choro\u00efdal Melanoma","volume":"20","author":"Brour","year":"2012","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archopht.1963.00960050788011","article-title":"Sympathetic Ophthalmia Associated with Malignant Melanoma","volume":"70","author":"Easom","year":"1963","journal-title":"Arch. Ophthalmol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ophtha.2008.12.027","article-title":"Palladium-103 Ophthalmic Plaque Radiation Therapy for Choroidal Melanoma: 400 Treated Patients","volume":"116","author":"Finger","year":"2009","journal-title":"Ophthalmology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/bjophthalmol-2014-305313","article-title":"Transpalpebral Proton Beam Radiotherapy of Choroidal Melanoma","volume":"99","author":"Konstantinidis","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brachy.2015.12.001","article-title":"Brachytherapy vs. External Beam Radiotherapy for Choroidal Melanoma: Survival and Patterns-of-Care Analyses","volume":"15","author":"Abrams","year":"2016","journal-title":"Brachytherapy"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1442-9071.2000.00354.x","article-title":"Iodine-125 Episcleral Plaque Therapy in Uveal Melanoma","volume":"28","author":"Sia","year":"2000","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/153303460800700503","article-title":"Development of a Streamlined, Non-Invasive Robotic Radiosurgery Method for Treatment of Uveal Melanoma","volume":"7","author":"Muacevic","year":"2008","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13014-018-1088-9","article-title":"Linear Accelerator-Based Stereotactic Fractionated Photon Radiotherapy as an Eye-Conserving Treatment for Uveal Melanoma","volume":"13","author":"Akbaba","year":"2018","journal-title":"Radiat. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-009-9811-x","article-title":"Initial Results of Fractionated CyberKnife Radiosurgery for Uveal Melanoma","volume":"94","author":"Zorlu","year":"2009","journal-title":"J. Neurooncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bjophthalmol-2017-310688","article-title":"Ruthenium-106 Brachytherapy for Iris and Iridociliary Melanomas","volume":"102","author":"Marinkovic","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ophtha.2013.10.032","article-title":"Proton Therapy for Uveal Melanoma in 43 Juvenile Patients: Long-Term Results","volume":"121","author":"Petrovic","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0039-6257(88)90088-4","article-title":"Cataracts Induced by Microwave and Ionizing Radiation","volume":"33","author":"Lipman","year":"1988","journal-title":"Surv. Ophthalmol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.brachy.2017.11.004","article-title":"Ruthenium Brachytherapy for Uveal Melanomas: Factors Affecting the Development of Radiation Complications","volume":"17","author":"Pagliara","year":"2018","journal-title":"Brachytherapy"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5114\/jcb.2021.103586","article-title":"Plaque Brachytherapy in Iris and Iridociliary Melanoma: A Systematic Review of Efficacy and Complications","volume":"13","author":"Karimi","year":"2021","journal-title":"J. Contemp. Brachyther."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Collaborative Ocular Melanoma Study Group (2007). Incidence of Cataract and Outcomes after Cataract Surgery in the First 5 Years after Iodine 125 Brachytherapy in the Collaborative Ocular Melanoma Study. COMS Report No. 27. Ophthalmology, 114, 1363\u20131371.","DOI":"10.1016\/j.ophtha.2006.10.039"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000433546","article-title":"Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency","volume":"2","author":"Weber","year":"2016","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4236\/jct.2016.73018","article-title":"Complications from Plaque versus Proton Beam Therapy for Choroidal Melanoma: A Qualitative Systematic Review","volume":"07","author":"Tseng","year":"2016","journal-title":"J. Cancer Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1167\/iovs.17-22557","article-title":"Cataract Avoidance with Proton Therapy in Ocular Melanomas","volume":"58","author":"Thariat","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/1120672118776146","article-title":"Regression Patterns of Choroidal Melanoma: After Palladium-103 (103Pd) Plaque Brachytherapy","volume":"28","author":"Maheshwari","year":"2018","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.clon.2016.01.034","article-title":"Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma","volume":"28","author":"Verma","year":"2016","journal-title":"Clin. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ijrobp.2011.10.017","article-title":"Outcomes of Proton Radiation Therapy for Peripapillary Choroidal Melanoma at the BC Cancer Agency","volume":"83","author":"Tran","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00417-017-3737-3","article-title":"Neovascular Glaucoma after Proton Beam Therapy of Choroidal Melanoma: Incidence and Risk Factors","volume":"255","author":"Riechardt","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.radonc.2010.03.023","article-title":"Long-Term Outcomes of Eye-Conserving Treatment with Ruthenium106 Brachytherapy for Choroidal Melanoma","volume":"95","author":"Verschueren","year":"2010","journal-title":"Radiother. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/eye.2016.49","article-title":"Transscleral Resection without Hypotensive Anaesthesia vs Iodine-125 Plaque Brachytherapy in the Treatment of Choroidal Melanoma","volume":"30","author":"Caminal","year":"2016","journal-title":"Eye"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bjophthalmol-2017-310801","article-title":"Predictors of Radio-Induced Visual Impairment after Radiosurgery for Uveal Melanoma","volume":"102","author":"Gigliotti","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00417-012-2144-z","article-title":"Gamma-Knife-Based Stereotactic Radiosurgery for Medium- and Large-Sized Posterior Uveal Melanoma","volume":"251","author":"Sarici","year":"2013","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e1458","DOI":"10.1111\/aos.14814","article-title":"Predictive Factors of Radio-Induced Complications in 194 Eyes Undergoing Gamma Knife Radiosurgery for Uveal Melanoma","volume":"99","author":"Cicinelli","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjo.2004.052159","article-title":"Laser Photocoagulation for Radiation Retinopathy after Ophthalmic Plaque Radiation Therapy","volume":"89","author":"Finger","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000501971","article-title":"Gamma Knife Radiosurgery for Uveal Melanoma: A Retrospective Review of Clinical Complications in a Tertiary Referral Center","volume":"6","author":"Modorati","year":"2020","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.brachy.2018.07.002","article-title":"Outcomes of Choroidal Melanomas Treated with Eye Physics Plaques: A 25-Year Review","volume":"17","author":"Le","year":"2018","journal-title":"Brachytherapy"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamaophthalmol.2014.111","article-title":"Plaque Radiotherapy for Juxtapapillary Choroidal Melanoma: Treatment Complications and Visual Outcomes in 650 Consecutive Cases","volume":"132","author":"Sagoo","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0161-6420(87)33439-6","article-title":"Uveal Melanomas Near the Optic Disc or Fovea","volume":"94","author":"Seddon","year":"1987","journal-title":"Ophthalmology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"754108","DOI":"10.3389\/fonc.2021.754108","article-title":"Long-Term Outcomes in Uveal Melanoma after Ruthenium-106 Brachytherapy","volume":"11","author":"Cennamo","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/aos.15029","article-title":"Fractionated Stereotactic Radiotherapy for Uveal Melanoma: Long-Term Outcome and Control Rates","volume":"100","author":"Baart","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/bjo.2008.153429","article-title":"Stereotactic Radiotherapy for Treatment of Juxtapapillary Choroidal Melanoma: 3-Year Follow-Up","volume":"93","author":"Krema","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1016\/j.ijrobp.2011.05.012","article-title":"Stereotactic Fractionated Radiotherapy in the Treatment of Juxtapapillary Choroidal Melanoma: The Mcgill University Experience","volume":"81","author":"Shun","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.ophtha.2009.12.015","article-title":"Natural History of Radiation Papillopathy after Proton Beam Irradiation of Parapapillary Melanoma","volume":"117","author":"Kim","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaophthalmol.2019.5132","article-title":"Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma","volume":"138","author":"Shields","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular Complications Following I-125 Brachytherapy for Choroidal Melanoma","volume":"23","author":"Wen","year":"2009","journal-title":"Eye"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.survophthal.2020.08.007","article-title":"Treatment of Radiation Maculopathy and Radiation-Induced Macular Edema: A Systematic Review","volume":"66","author":"Fallico","year":"2021","journal-title":"Surv. Ophthalmol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhang, R., Wang, Y., Chen, R., Liu, Y., Li, Y., and Wei, W. (2022). Retrospective Analysis of Secondary Enucleation for Uveal Melanoma after Plaque Radiotherapy. BMC Ophthalmol., 22.","DOI":"10.1186\/s12886-022-02387-x"},{"key":"ref_110","first-page":"230","article-title":"Intravitreal Fluocinolone Acetonide Implant for Radiation Retinopathy: Report of Preliminary Findings","volume":"8","author":"Singaravelu","year":"2023","journal-title":"Retina"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1167\/iovs.13-12951","article-title":"Control of Photoreceptor Autophagy After Retinal Detachment: The Switch From Survival to Death","volume":"55","author":"Chinskey","year":"2014","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/IAE.0000000000001337","article-title":"External Drainage for Primary Surgical Management of Uveal Melanoma Exudative Retinal Detachment","volume":"37","author":"McCannel","year":"2017","journal-title":"Retina"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5114\/jcb.2019.90985","article-title":"Analysis of Local Recurrence Causes in Uveal Melanoma Patients Treated with 125I Brachytherapy - A Single Institution Study","volume":"11","author":"Kowal","year":"2019","journal-title":"J. Contemp. Brachytherapy"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2012.06.026","article-title":"Intravitreal Triamcinolone Versus Intravitreal Bevacizumab in the Treatment of Exudative Retinal Detachment Secondary to Posterior Uveal Melanoma","volume":"155","author":"Parrozzani","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Zhou, X., Ishikawa, H., and Gomi, F. (2022). Macular Hole and Vitreous Hemorrhage Subsequent to Stereotactic Hypofractionated Radiotherapy for Choroidal Melanoma: A Case Report and Review of the Literature. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1060307"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/jamaophthalmol.2017.3805","article-title":"Long-Term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas","volume":"135","author":"Papakostas","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jamaophthalmol.2013.5677","article-title":"Palladium-103 Plaque Radiation Therapy for American Joint Committee on Cancer T3- and T4-Staged Choroidal Melanomas","volume":"132","author":"Semenova","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ajo.2014.02.032","article-title":"Proton Beam Therapy of Parapapillary Choroidal Melanoma","volume":"157","author":"Riechardt","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Mills, M.D., and Harbour, J.W. (2006). Lipid Exudation Following Plaque Radiotherapy for Posterior Uveal Melanoma. Am. J. Ophthalmol., 141.","DOI":"10.1016\/j.ajo.2005.10.015"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00417-019-04413-z","article-title":"Breakdown of the Blood-Eye Barrier in Choroidal Melanoma after Proton Beam Radiotherapy","volume":"257","author":"Hager","year":"2019","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IJG.0000000000001393","article-title":"Glaucoma after Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors","volume":"29","author":"Kim","year":"2020","journal-title":"J. Glaucoma"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","article-title":"Risk Factors for Neovascular Glaucoma after Proton Beam Therapy of Uveal Melanoma: A Detailed Analysis of Tumor and Dose-Volume Parameters","volume":"87","author":"Mishra","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ijrobp.2006.08.080","article-title":"Risk Factors for Neovascular Glaucoma after Carbon Ion Radiotherapy of Choroidal Melanoma Using Dose-Volume Histogram Analysis","volume":"67","author":"Hirasawa","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bjophthalmol-2012-302808","article-title":"A Comparison between 125Iodine Brachytherapy and Stereotactic Radiotherapy in the Management of Juxtapapillary Choroidal Melanoma","volume":"97","author":"Krema","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/COC.0000000000000775","article-title":"Systematic Review and Meta-Analysis on the Use of Photon-Based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma","volume":"44","author":"Kosydar","year":"2021","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3129\/i08-171","article-title":"Intracameral Bevacizumab in the Treatment of Neovascular Glaucoma and Exudative Retinal Detachment after Brachytherapy in Choroidal Melanoma","volume":"44","author":"Somani","year":"2009","journal-title":"Can. J. Ophthalmol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1442-9071.2004.00917.x","article-title":"Developments in the Management of Uveal Melanoma","volume":"32","author":"Damato","year":"2004","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(97)00088-X","article-title":"Radiation Therapy for Choroidal Melanoma","volume":"42","author":"Finger","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2005.02.017","article-title":"Local Tumor Control after 106Ru Brachytherapy of Choroidal Melanoma","volume":"63","author":"Damato","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Jung, S.-K., Park, Y.-H., Shin, D., Kim, H.-S., Jung, J.-H., Kim, T.-H., and Moon, S.H. (2020). Visual Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in the Republic of Korea. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0242966"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bjophthalmol-2012-302399","article-title":"Visual Acuity after Gamma-Knife Radiosurgery of Choroidal Melanomas","volume":"97","author":"Wackernagel","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","article-title":"Eye Retention after Proton Beam Radiotherapy for Uveal Melanoma","volume":"55","author":"Egger","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ophtha.2004.11.038","article-title":"Ruthenium Brachytherapy for Uveal Melanoma, 1979\u20132003: Survival and Functional Outcomes in the Swedish Population","volume":"112","author":"Bergman","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/bjo.2010.195594","article-title":"Proton Beam Therapy for the Treatment of Uveal Melanoma in Scotland","volume":"95","author":"Macdonald","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","article-title":"Proton Beam Radiotherapy of Choroidal Melanoma: The Liverpool-Clatterbridge Experience","volume":"62","author":"Damato","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/17469899.2014.921119","article-title":"Management of Conjunctival Malignant Melanoma: A Review and Update","volume":"9","author":"Wong","year":"2014","journal-title":"Expert. Rev. Ophthalmol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5114\/jcb.2019.82888","article-title":"Personalized Re-Treatment Strategy for Uveal Melanoma Local Recurrences after Interventional Radiotherapy (Brachytherapy): Single Institution Experience and Systematic Literature Review","volume":"11","author":"Tagliaferri","year":"2019","journal-title":"J. Contemp. Brachytherapy"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Negretti, G.S., Harley, U., Arora, A.K., Hay, G., Sagoo, M.S., and Damato, B.E. (2021). Detecting Progression of Treated Choroidal Melanomas: Is Ultrasonography Necessary?. Cancers, 13.","DOI":"10.3390\/cancers13225832"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","article-title":"Local Treatment Failure after Globe-Conserving Therapy for Choroidal Melanoma","volume":"97","author":"Chang","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Bagger, M., Espensen, C., Rasmussen, K., Dogrus\u00f6z, M., Jager, M.J., Appelt, A., and Kiilgaard, J.F. (2023). Genetic Status Affects Disease-Specific Mortality but Not the Incidence of Local Recurrence in Patients with Uveal Melanoma. Ophthalmology.","DOI":"10.1016\/j.ophtha.2023.03.010"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/pon.1046","article-title":"The Impact of Diagnosis and Plaque Radiotherapy Treatment of Malignant Choroidal Melanoma on Patients\u2019 Quality of Life","volume":"15","author":"Reimer","year":"2006","journal-title":"Psychooncology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ecc.12001","article-title":"Translation and Validation of the Polish Version of the EORTC QLQ-OPT30 Module for the Assessment of Health-Related Quality of Life in Patients with Uveal Melanoma","volume":"22","author":"Chmielowska","year":"2013","journal-title":"Eur. J. Cancer Care"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.eye.6700639","article-title":"The EORTC Ophthalmic Oncology Quality of Life Questionnaire Module (EORTC QLQ-OPT30). Development and Pre-Testing (Phase I-III)","volume":"18","author":"Brandberg","year":"2004","journal-title":"Eye (Lond.)"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1600-0420.2003.0210.x","article-title":"Influence of Uveal Melanoma Therapy on Patients\u2019 Quality of Life: A Psychological Study","volume":"82","author":"Chabert","year":"2004","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archopht.117.4.461","article-title":"Treatment Choice and Quality of Life in Patients With Choroidal Melanoma","volume":"117","author":"Cruickshanks","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"ref_146","first-page":"97","article-title":"Quality of Life and Psychological State in Patients with Choroidal Melanoma: Longitudinal Study","volume":"98","author":"Dolbeault","year":"2011","journal-title":"Bull. Cancer"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00417-015-3216-7","article-title":"Quality of Life in the Follow-up of Uveal Melanoma Patients after Enucleation in Comparison to CyberKnife Treatment","volume":"254","author":"Klingenstein","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/eye.2016.188","article-title":"Two-Year Patient-Reported Outcomes Following Treatment of Uveal Melanoma","volume":"30","author":"Brown","year":"2016","journal-title":"Eye (Lond)"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000502549","article-title":"Quality of Life Concerns in Patients with Uveal Melanoma after Initial Diagnosis","volume":"6","author":"Barker","year":"2020","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/eye.2000.233","article-title":"Psychological Reactions and Quality of Life in Patients with Posterior Uveal Melanoma Treated with Ruthenium Plaque Therapy or Enucleation: A One Year Follow-up Study","volume":"14","author":"Brandberg","year":"2000","journal-title":"Eye (Lond.)"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000496927","article-title":"Patient-Reported Outcomes and Quality of Life after Treatment for Choroidal Melanoma","volume":"5","author":"Damato","year":"2019","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archopht.121.7.1010","article-title":"Collaborative Ocular Melanoma Study-Quality Of Life Study Group. Development and Validation of Disease-Specific Measures for Choroidal Melanoma","volume":"121","author":"Melia","year":"2003","journal-title":"Arch. Ophthalmol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/7\/470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:05:12Z","timestamp":1760126712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/7\/470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":152,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["curroncol30070470"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30070470","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]}}}